Showing 11-15 of 16 comparative analytics:
Outcomes By Race In Breast Cancer Screening With Digital Breast Tomosynthesis Versus Digital Mammography

Journal of the American College of Radiology Published: February 16, 2021 Read the Full Manuscript >> Abstract Purpose Digital breast tomosynthesis (DBT) in conjunction with digital mammography (DM) is becoming the preferred imaging modality for breast cancer screening compared with DM alone, on the basis of improved recall rates (RR) and cancer detection rates (CDRs).[…]

Analysis of Real-Word Data in Cardiovascular Disease: Missing Data and Predictive Modeling

Tues. January 26, 2021 2:00-3:00 PM Register Real-world data (RWD) is playing an increasing role in health care decisions, especially with cardiovascular conditions such as heart failure where risk of mortality is high and comorbidities, varying symptom presentation, and disease progression drastically determine treatment pathways and outcomes. Join OM1’s Chief Medical Officer Dr. Gary Curhan[…]

How can AI and RWD work together to improve understanding of chronic diseases? Q&A with Kathryn Starzyk, Head of RWE at OM1

August 13, 2020- Aetion In a recent interview, Kathryn Starzyk, epidemiologist and Head of Real-World Evidence (RWE) at OM1, shared what makes OM1’s data unique, and how she and her team partner with biopharma and health systems to generate RWE that helps researchers better understand patient journeys in disease areas including rheumatology and immunology. Read on[…]